Румунија - Румунски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 250mg - chinolone antibacteriene fluorochinolone

Румунија - Румунски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 500mg - chinolone antibacteriene fluorochinolone

Румунија - Румунски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 750mg - chinolone antibacteriene fluorochinolone

Румунија - Румунски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 250mg - chinolone antibacteriene fluorochinolone

Румунија - Румунски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 500mg - chinolone antibacteriene fluorochinolone

Румунија - Румунски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

apl swift services (malta) limited - malta - ciprofloxacinum - compr. film. - 750mg - chinolone antibacteriene fluorochinolone

Европска Унија - Румунски - EMA (European Medicines Agency)

dynavax gmbh - hepatita b antigen de suprafață - hepatita b - vaccinuri - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Европска Унија - Румунски - EMA (European Medicines Agency)

vbi vaccines b.v. - hepatita b antigen de suprafață - hepatita b - vaccinuri - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.